Samuel S Lee,Sarah A Williams,Jacqueline Pinto et al.
Samuel S Lee et al.
Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature [0.03%]
自身免疫性小儿后巨细胞肝炎的病例报告和文献回顾
Yasi Xiao,Zu-Hua Gao,Marc Deschenes
Yasi Xiao
Giant cell hepatitis (GCH) is a rare entity in adults that is characterized by large multinucleated hepatocyte formation and parenchymal inflammation. We present a case of acute liver failure in a 33-year-old woman secondary to autoimmune h...
Alcohol product warning labels to deter alcohol misuse and prevent alcohol-related diseases: a call to action in Canada [0.03%]
加拿大采取行动防止酒精误用和预防与饮酒相关的疾病的酒精产品警示标签
Man Ting Kristina Yau,Natasha Chandok,Eric M Yoshida
Man Ting Kristina Yau
A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians [0.03%]
加拿大关于医师对非酒精性脂肪肝疾病认知的调查
Giada Sebastiani,Alnoor Ramji,Mark G Swain et al.
Giada Sebastiani et al.
Background: In Canada, non-alcoholic fatty liver disease (NAFLD) is the most frequently occurring liver disease, affecting one in four Canadians. NAFLD can in turn evolve into non-alcoholic steatohepatitis (NASH) and cirr...
IgG4-associated autoimmune hepatitis and cholangitis: A relatively novel entity to consider in cases of seronegative autoimmune hepatitis [0.03%]
与自身免疫性肝炎相关的IgG4相关性自身免疫性疾病：在自身抗体阴性的自身免疫性肝炎中需要考虑的一个相对新颖的疾病实体
Gabrielle Jutras,Philip Wong,José Ferreira et al.
Gabrielle Jutras et al.
A 49-year-old woman with no inflammatory bowel disease history presented to our clinic with abnormal liver function tests and right upper quadrant abdominal pain. Blood tests revealed a mixed pattern of liver injury. Abdominal magnetic reso...
Colin Rumbolt,Gerald Y Minuk
Colin Rumbolt
The estimated global prevalence of alcohol abuse is 5%-15%, with 15%-20% of these individuals being considered binge drinkers. Despite the high prevalence, the effects of binge drinking on healthy and diseased livers remain unclear. This re...
Jordan Feld
Jordan Feld
Liver biopsy complication rates in patients with non-alcoholic fatty liver disease [0.03%]
非酒精性脂肪肝病患者的肝活检并发症发生率
Felix Zhou,Ashley Stueck,Magnus McLeod
Felix Zhou
Background: With new treatments for non-alcoholic fatty liver disease (NAFLD) on the horizon, it will be important to risk-stratify patients based on degree of fibrosis to allocate treatment to those at highest risk. No s...